← Leaderboards
Andrew Patrick Ambrosy
Kaiser Foundation Research Institute
$3,769,946
Attributed
$7,077,579
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.1M · FY2020–25$10M$7.5M$5M$2.5M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,579,115 · 3
FDA$1,498,464 · 1
By mechanism
R01$4,617,315 · 2
U01$1,498,464 · 1
K23$961,800 · 1
Top collaborators
- Elizabeth Marjorie Cespedes Feliciano1 shared
- Parag Goyal1 shared
- David Ouyang1 shared
- Alexander Sandhu1 shared
Most similar at Kaiser Foundation Research Institute
Same institution · by research overlap
- Gregory E Simon$47,932,393
- Song Yao$11,329,919
- Laura Gottlieb$3,554,427
- Rachel Gold$17,398,894
- Nikki Carroll$909,145
Others in their field
Other Emerging Leaders on “Guidelines”
- Kimberly Smith · Ppd Development Lp$115,671,664
- Martha Hering · Westat, Inc.$57,098,843
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$52,725,737
- Michelle Lynn Sever · Rho Federal Systems Division, Inc.$26,732,375
- Leigh A Johnson · University Of North Texas Hlth Sci Ctr$21,969,486
- Ellen Gould Chadwick · Harvard University D/B/A Harvard School Of Public Health$21,828,548
Research focus
GuidelinesEventHealth SystemFutureCaliforniaDesignInnovationNatural Language ProcessingInternationalPharmaceutical PreparationsEpidemiologyInterestDeep LearningLearningHospitalizationAlgorithmsImpairmentCardiacCaringEvidence BaseHigh RiskCohortHealth Related Quality Of LifePhysicians
Grant awards (8)
Harnessing Artificial Intelligence and Deep Learning to Determine a Coronary Artery Calcium Estimate in Patients with No History of AtheroSclerotic CardioVascular Disease (HIDDEN-ASCVD) Study$3,918,561
R01 · FY2025 · HL · contact PI
AI-Enabled Echocardiographic Biomarkers and Real-World Data for Predicting Cancer Therapy-Related Cardiac Dysfunction$1,498,464
U01 · FY2025 · FD
DEPRESCRIBE-HFPEF$698,754
R01 · FY2025 · AG
Outpatient Worsening Heart Failure in an Integrated Health Care Delivery System: An Innovative Approach to Characterizing a Novel Clinical Entity$193,320
K23 · FY2024 · HL · contact PI
Outpatient Worsening Heart Failure in an Integrated Health Care Delivery System: An Innovative Approach to Characterizing a Novel Clinical Entity$192,120
K23 · FY2023 · HL · contact PI
Outpatient Worsening Heart Failure in an Integrated Health Care Delivery System: An Innovative Approach to Characterizing a Novel Clinical Entity$192,120
K23 · FY2022 · HL · contact PI
Outpatient Worsening Heart Failure in an Integrated Health Care Delivery System: An Innovative Approach to Characterizing a Novel Clinical Entity$192,120
K23 · FY2021 · HL · contact PI
Outpatient Worsening Heart Failure in an Integrated Health Care Delivery System: An Innovative Approach to Characterizing a Novel Clinical Entity$192,120
K23 · FY2020 · HL · contact PI